 Transrectal High-intensity Focused Ultrasound HIFU is a minimally-invasive therapy for prostate cancer that is currently assessed in two indications: as a first-line treatment either total or focal for patients who are not eligible for surgery and as a salvage treatment of local recurrences after radiotherapy. 